Jeanette S Brown1, Eric Vittinghoff, Feng Lin, Leroy M Nyberg, John W Kusek, Alka M Kanaya. 1. Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF Women's Health Clinical Research Center, University of California-San Francisco, 1635 Divisadero Street, Suite 600, San Francisco, CA 94115, USA. brownj@obgyn.ucsf.edu
Abstract
OBJECTIVE: Diabetes is associated with increased risk of urinary incontinence. It is unknown whether women with pre-diabetes, or impaired fasting glucose (IFG), have increased prevalence of incontinence. We determined the prevalence of, and risk factors for, incontinence among U.S. women with diabetes and IFG. RESEARCH DESIGN AND METHODS: The 2001-2002 National Health and Nutrition Examination Survey measured fasting plasma glucose and obtained information about diabetes and urinary incontinence among 1,461 nonpregnant adult women. Self-reported weekly or more frequent incontinence, both overall and by type (urge and stress), was our outcome. RESULTS: Of the 1,461 women, 17% had diabetes and 11% met criteria for IFG. Prevalence of weekly incontinence was similar among women in these two groups (35.4 and 33.4%, respectively) and significantly higher than among women with normal fasting glucose (16.8%); both urge and stress incontinence were increased. In addition to well-recognized risk factors including age, weight, and oral estrogen use, two microvascular complications caused by diabetes, specifically macroalbuminuria and peripheral neuropathic pain, were associated with incontinence. CONCLUSIONS: Physicians should be alert for incontinence, an often unrecognized and therefore undertreated disorder, among women with diabetes and IFG, in particular those with microvascular complications. The additional prospect of improvements in their incontinence may help motivate some high-risk women to undertake difficult lifestyle changes to reduce their more serious risk of diabetes and its sequelae.
OBJECTIVE:Diabetes is associated with increased risk of urinary incontinence. It is unknown whether women with pre-diabetes, or impaired fasting glucose (IFG), have increased prevalence of incontinence. We determined the prevalence of, and risk factors for, incontinence among U.S. women with diabetes and IFG. RESEARCH DESIGN AND METHODS: The 2001-2002 National Health and Nutrition Examination Survey measured fasting plasma glucose and obtained information about diabetes and urinary incontinence among 1,461 nonpregnant adult women. Self-reported weekly or more frequent incontinence, both overall and by type (urge and stress), was our outcome. RESULTS: Of the 1,461 women, 17% had diabetes and 11% met criteria for IFG. Prevalence of weekly incontinence was similar among women in these two groups (35.4 and 33.4%, respectively) and significantly higher than among women with normal fasting glucose (16.8%); both urge and stress incontinence were increased. In addition to well-recognized risk factors including age, weight, and oral estrogen use, two microvascular complications caused by diabetes, specifically macroalbuminuria and peripheral neuropathic pain, were associated with incontinence. CONCLUSIONS: Physicians should be alert for incontinence, an often unrecognized and therefore undertreated disorder, among women with diabetes and IFG, in particular those with microvascular complications. The additional prospect of improvements in their incontinence may help motivate some high-risk women to undertake difficult lifestyle changes to reduce their more serious risk of diabetes and its sequelae.
Authors: Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112
Authors: Susan L Hendrix; Barbara B Cochrane; Ingrid E Nygaard; Victoria L Handa; Vanessa M Barnabei; Cheryl Iglesia; Aaron Aragaki; Michelle J Naughton; Robert B Wallace; S Gene McNeeley Journal: JAMA Date: 2005-02-23 Impact factor: 56.272
Authors: Karen L Lifford; Gary C Curhan; Frank B Hu; Robert L Barbieri; Francine Grodstein Journal: J Am Geriatr Soc Date: 2005-11 Impact factor: 5.562
Authors: Jeanette S Brown; Rena Wing; Elizabeth Barrett-Connor; Leroy M Nyberg; John W Kusek; Trevor J Orchard; Yong Ma; Eric Vittinghoff; Alka M Kanaya Journal: Diabetes Care Date: 2006-02 Impact factor: 19.112
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Stephanie M Benjamin; Rodolfo Valdez; Linda S Geiss; Deborah B Rolka; K M Venkat Narayan Journal: Diabetes Care Date: 2003-03 Impact factor: 19.112
Authors: Ashmi M Doshi; Stephen K Van Den Eeden; Michelle Y Morrill; Michael Schembri; David H Thom; Jeanette S Brown Journal: J Urol Date: 2010-08-19 Impact factor: 7.450
Authors: Aruna V Sarma; Alka Kanaya; Leroy M Nyberg; John W Kusek; Eric Vittinghoff; Brandy Rutledge; Patricia A Cleary; Patricia Gatcomb; Jeanette S Brown Journal: Urology Date: 2009-04-10 Impact factor: 2.649
Authors: Maryellen S Kelly; Jonathan C Routh; Leah G Davis; J Todd Purves; John S Wiener; Matthew L Maciejewski Journal: Clin Pediatr (Phila) Date: 2018-08-27 Impact factor: 1.168
Authors: Suzanne Phelan; Alka M Kanaya; Leslee L Subak; Patricia E Hogan; Mark A Espeland; Rena R Wing; Kathryn L Burgio; Vicki Dilillo; Amy A Gorin; Delia S West; Jeanette S Brown Journal: Diabetes Care Date: 2009-06-01 Impact factor: 19.112